We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$1.43B
AUM Growth
+$297M
Cap. Flow
+$228M
Cap. Flow %
16%
Top 10 Hldgs %
15.34%
Holding
1,414
New
222
Increased
745
Reduced
184
Closed
249

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$11.4M
2
AAPL icon
Apple
AAPL
+$9.16M
3
MSFT icon
Microsoft
MSFT
+$6.62M
4
META icon
Meta Platforms (Facebook)
META
+$5.96M
5
AMZN icon
Amazon
AMZN
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 18.28%
2 Financials 14.25%
3 Healthcare 11.99%
4 Industrials 10.61%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETD icon
1101
Ethan Allen Interiors
ETD
$581M
$16K ﹤0.01%
557
-189
-25% -$5.55K
MOV icon
1102
Movado Group
MOV
$812M
$16K ﹤0.01%
499
-297
-37% -$8.61K
RTEC
1103
DELISTED
Rudolph Technologies Inc
RTEC
$16K ﹤0.01%
685
-296
-30% -$7.6K
CATO icon
1104
Cato Corp
CATO
$65.9M
$15K ﹤0.01%
947
-105
-10% -$1.52K
CHRS icon
1105
Coherus Oncology
CHRS
$217M
$15K ﹤0.01%
+1,725
New +$18.5K
RGNX icon
1106
Regenxbio
RGNX
$623M
$15K ﹤0.01%
+450
New +$13.6K
OCLR
1107
DELISTED
Oclaro Inc.
OCLR
$15K ﹤0.01%
+2,187
New +$16.2K
ALOG
1108
DELISTED
Analogic Corp
ALOG
$15K ﹤0.01%
+183
New +$15.1K
ANGO icon
1109
AngioDynamics
ANGO
$562M
$14K ﹤0.01%
816
-349
-30% -$5.96K
INO icon
1110
Inovio Pharmaceuticals
INO
$79.8M
$14K ﹤0.01%
+288
New +$17.9K
TVTX icon
1111
Travere Therapeutics
TVTX
$5.33B
$14K ﹤0.01%
+650
New +$14.9K
PRFT
1112
DELISTED
Perficient Inc
PRFT
$14K ﹤0.01%
752
-388
-34% -$7.51K
EPZM
1113
DELISTED
Epizyme, Inc
EPZM
$14K ﹤0.01%
+1,100
New +$16K
PGNX
1114
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$14K ﹤0.01%
+2,400
New +$14.6K
AKBA icon
1115
Akebia Therapeutics
AKBA
$327M
$13K ﹤0.01%
+900
New +$14.9K
FF icon
1116
Future Fuel
FF
$204M
$13K ﹤0.01%
936
-936
-50% -$13.9K
MYE icon
1117
Myers Industries
MYE
$1.18B
$13K ﹤0.01%
649
-518
-44% -$10.9K
XNCR icon
1118
Xencor
XNCR
$1.44B
$13K ﹤0.01%
+575
New +$12.5K
FPRX
1119
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$13K ﹤0.01%
+607
New +$19.5K
KERX
1120
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$13K ﹤0.01%
+2,875
New +$15.8K
TCRT icon
1121
Alaunos Therapeutics
TCRT
$4.74M
$12K ﹤0.01%
+20
New +$14.4K
BFX
1122
DELISTED
BowFlex Inc.
BFX
$12K ﹤0.01%
927
+69
+8% +$999
RUTH
1123
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$12K ﹤0.01%
549
-368
-40% -$7.73K
CALA
1124
DELISTED
Calithera Biosciences, Inc
CALA
$12K ﹤0.01%
+74
New +$18.9K
RRTS
1125
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$12K ﹤0.01%
60
-33
-35% -$7.03K

Similar funds

Pacer Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Pacer Advisors held 1,414 positions worth $1.43B, up 26% from $1.13B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Pacer Advisors deployed $228M of net new capital in Q4 2017, opening 222 new positions and adding to 745 existing holdings. Its largest new stake was Equinor: 118,925 shares worth $2.55M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $3.14M trimmed.

  • Pacer Advisors's largest Q4 2017 buy was Equinor: 118,925 shares worth $2.55M.
  • Pacer Advisors added most to Alphabet (Google) Class A in Q4 2017, an estimated $11.4M increase.
  • Pacer Advisors's biggest Q4 2017 reduction was Alphabet (Google) Class C, cutting an estimated $3.14M.
  • Pacer Advisors fully exited Adient in Q4 2017, selling an estimated $1.67M.
  • Pacer Advisors's ten largest holdings make up 15% of its $1.43B portfolio in Q4 2017.
  • Pacer Advisors opened 222 new positions and closed 249 in Q4 2017.
  • Pacer Advisors's portfolio value rose 26% quarter-over-quarter to $1.43B.

Based on Pacer Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.